Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009, 153(4):297-302 | DOI: 10.5507/bp.2009.050
PROSTATE CANCER DETECTION YIELD IN REPEATED BIOPSY IS INDEPENDENT OF THE DIAGNOSIS OF EARLIER BIOPSIES
- a Department of Urology, Faculty of Medicine and Dentistry, Palacky University Olomouc,I.P. Pavlova 6, 775 20 Olomouc, Czech Republic,
- b Department of Mathematical analysis, Faculty of Science, Palacky University Olomouc, Tomkova 40, 779 00 Olomouc
- c Academy of Sciences of the Czech Republic, Institute of Computer Science, Pod Vodarenskou vezi 2, 182 07 Prague 8,
- Czech Republic
Background: We analyzed data gathered from initial and repeated prostate biopsies at the University Hospital in Olomouc, Czech Republic. We evaluated the diagnostic yield of repeated transrectal ultrasound (TRUS) guided biopsies. We also assessed whether the result of the repeated biopsy depended on the benign diagnosis of the previous biopsy.
Methods: From June 2006 till December 2008, the total of 794 men underwent a TRUS guided biopsy. The following parameters were recorded for each patient: age, total Prostatic Specific Antigen (PSA) level, free PSA level, digital rectal examination record, total prostate volume, and the histo-pathological evaluation. For patients undergoing a repeated biopsy, the histo-pathological result of the previous biopsy was also available, as well as the total number of previous biopsies and the time since the last biopsy. These data were analyzed using standard statistical methods.
Results: Initial biopsy was positive for prostate cancer in 157 out of 566 men (27.7%). The total PSA level was confirmed to be a significant (P < 0.001) predictor of prostate cancer. The ratio of free PSA to total PSA (the socalled PSA index) was found to be significantly lower (P < 0.001) for patients suffering from adenocarcinoma. A total of 191 men underwent a repeated biopsy. The repeated biopsy was positive for adenocarcinoma in 39 cases (20.4%). Although this yield is lower, the significance is at the threshold (P = 0.04700). In the group of rebiopted men, total PSA level and PSA index were again significant (P = 0.0024 and P = 0.0015 respectively) predictive factors for prostate carcinoma. The diagnostic yield of repeated biopsy was assessed with respect to the most common types of the benign findings in the previous biopsy - adenomyomatous hyperplasia, inflammation, high grade prostatic intraepithelial neoplasia, and suspected adenocarcinoma. No significant difference in the diagnostic yield was found (P = 0.38431).
Conclusions: Total PSA level and PSA index are the most significant precursors of adenocarcinoma in both initial and repeated biopsy. The histo-pathological result of a repeated biopsy was found to be independent of the type of benign diagnosis of the previous biopsy. A substantial number of prostate cancer is diagnosed in repeated biopsies which advocates for the indication of a repeated biopsy in case of a negative result of the initial one.
Keywords: Prostatic Specific Antigen, PSA Index, Repeated Biopsy, Adenocarcinoma
Received: August 13, 2009; Accepted: November 13, 2009; Published: December 1, 2009 Show citation
| ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Dusek L, Muzik J, Kubasek M, Koptikova J, Zaloudik J, Vyzula R. Epidemiology of malignant tumors in Czech Republic [online], Masaryk University, 2005, cited. 19. 2. 2009. Available at http:// www.svod.cz. Version 7.0 [2007], ISSN 18028861.
- Djavan B, Mazal P, Zlotta A, Wammack R, Ravery V, Remzi M, Susani M, Borkowski A, Hruby S, Boccon-Gibod L, Schulman CC, Marberger M. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: Result of the prospective european prostate cancer study. Prostate 2001;47(2):1117.
Go to original source...
Go to PubMed... - Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, Nadler RB. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 1995;274(15):121420.
Go to original source...
Go to PubMed... - Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, Cooner WH. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992;147(3 Pt 2):8156.
Go to original source... - Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM. Serum prostate specific antigen in a community- based population of healthy men. Establishment of agespecific reference ranges. JAMA 1993;270(7):8604.
Go to original source...
Go to PubMed... - Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, Fozard JL, Walsh PC. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992;267(16):221520.
Go to original source...
Go to PubMed... - Djavan B, Ravery V, Zlotta A, Dobronski P, Dobrovits M, Fakhari M, Seitz C, Susani M, Borkowski A, Boccon-Gibod L, Schulman CC, Marberger M. Prospective evaluation of prostate cancer detected on biopsies 1,2,3 and 4; when should we stop? J Urol 2001;166(5):167983.
Go to original source...
Go to PubMed... - Heidenreich A, Aus G, Abbou CC, Bolla M, Joniau S, Matveev V, Schmid HP, Zattoni F. Guidelines on Prostate Cancer. European Association of Urology, cited 20. 2. 2009. Available at www.uroweb. org/fileadmin/user_upload/Guidelines/07_Prostate_Cancer_2007. pdf.
Go to original source... - Zlotta AR, Raviv G, Schulman CC. Clinical prognostic criteria for later diagnosis of prostate carcinoma patients with initial isolated prostatic intraepithelial neoplasia. Eur Urol 1996;30(2):24955.
Go to original source... - Haggman MJ, Macoska JA, Wojno KJ, Oesterling JE. The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues. J Urol 1997;158(1):1222.
Go to original source...
Go to PubMed... - Iczkowski KA, Cheng L, Qian J, et al. ASAP is a valid diagnosis. Atypical small acinar proliferation. Hum Pathol 1999;30(12):1403 4.
Go to original source...
Go to PubMed... - Neal DE, Clean S, Sarma D, Moon TD. Prostate specific antigen and prostatitis. I: Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate 1992;20(2):10511.
Go to original source...
Go to PubMed... - Okada K, Kojima M, Naya Y, Kamoi K, Yokoyama K, Takamatsu T, Miki T. Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer. Urology 2000;55(6):8928.
Go to original source...
Go to PubMed... - Jung, K, Meyer, A, Lein, M, et al. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate. J Urol 1998;159(5):15958.
Go to original source...
Go to PubMed... - Djavan B, Zlotta A, Remzi M, Ghawidel K, Baskharkhan A Schulman CC, Mrberger M. Optimal predictors of prostate cancer on repeat biopsy: A prospective study of 1,051 men. J Urol 2000;163(4):11448; discussion 11489.
Go to original source...
Go to PubMed... - Keetch DW, McMurtry JM, Smith DS, Andriole GL, Catalona WJ. Prostate Specific Antigen Density Versus Prostate Specific Antigen Slope as Predictors of Prostate Cancer in Men with Initially Negative Prostatic Biopsies. J Urol 1996;156(2 Pt 1):42831.
Go to original source...
Go to PubMed... - Djavan B, Waldert M, Zlotta A, Dobronski P, Seitz C, Remzi M, Borkowski A, Schulman C, Marberger M. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: Result of a Prospective European Prostate Cancer Detection Study. J Urol 2001;166(3):85660.
Go to original source...
Go to PubMed...




